Kathleen Goetz's most recent trade in Tandem Diabetes Care Inc was a trade of 8,759 Restricted Stock Unit done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 8,759 | 8,759 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.64 per share. | 21 May 2025 | 4,387 | 17,853 (0%) | 0% | 20.6 | 90,548 | Common Stock |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 4,387 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 4,434 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.73 per share. | 22 May 2024 | 4,434 | 13,466 (0%) | 0% | 51.7 | 229,371 | Common Stock |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,387 | 4,387 | - | - | Restricted Stock Unit | |
| Tekla Healthcare Opportuni... | Kathleen L. Goetz | Director | Purchase of securities on an exchange or from another person at price $ 19.54 per share. | 09 Apr 2024 | 600 | 1,148 (0%) | 0% | 19.5 | 11,723 | Common Stock |
| Tekla Healthcare Investors | Kathleen L. Goetz | Director | Purchase of securities on an exchange or from another person at price $ 16.42 per share. | 09 Apr 2024 | 525 | 1,079 (0%) | 0% | 16.4 | 8,622 | Common Stock |
| Tekla Life Sciences Investors | Kathleen L. Goetz | Director | Purchase of securities on an exchange or from another person at price $ 13.32 per share. | 09 Apr 2024 | 400 | 1,085 (0%) | 0% | 13.3 | 5,327 | Common Stock |
| Tekla World Healthcare Fund | Kathleen L. Goetz | Director | Purchase of securities on an exchange or from another person at price $ 12.53 per share. | 09 Apr 2024 | 200 | 1,017 (0%) | 0% | 12.5 | 2,506 | Common Stock |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 1,220 | 8,032 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 1,220 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 4,434 | 4,434 | - | - | RSU 2023 05 24 | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 6,812 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 1,220 | 4,055 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 1,220 | 1,220 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,021 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,021 | 2,835 (0%) | 0% | 0 | Common Stock | |
| Tekla World Healthcare Fund | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 14.57 per share. | 23 Mar 2022 | 103 | 817 (0%) | 0% | 14.6 | 1,501 | Shares of Beneficial Interest |
| Tekla Life Sciences Investors | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 16.33 per share. | 23 Mar 2022 | 92 | 685 (0%) | 0% | 16.3 | 1,502 | Shares of Beneficial Interest |
| Tekla Healthcare Investors | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 20.56 per share. | 23 Mar 2022 | 73 | 554 (0%) | 0% | 20.6 | 1,501 | Shares of Beneficial Interest |
| Tekla Healthcare Opportuni... | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 21.74 per share. | 23 Mar 2022 | 69 | 548 (0%) | 0% | 21.7 | 1,500 | Shares of Beneficial Interest |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Sale of securities on an exchange or to another person at price $ 106.00 per share. | 14 Mar 2022 | 405 | 814 (0%) | 0% | 106 | 42,930 | Common Stock |
| Tekla World Healthcare Fund | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 14.60 per share. | 26 Jan 2022 | 714 | 714 (0%) | 0% | 14.6 | 10,426 | Shares of Beneficial Interest |
| Tekla Life Sciences Investors | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 17.54 per share. | 26 Jan 2022 | 593 | 593 (0%) | 0% | 17.5 | 10,404 | Shares of Beneficial Interest |
| Tekla Healthcare Investors | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 21.52 per share. | 26 Jan 2022 | 481 | 481 (0%) | 0% | 21.5 | 10,349 | Shares of Beneficial Interest |
| Tekla Healthcare Opportuni... | Kathleen Goetz | Director | Purchase of securities on an exchange or from another person at price $ 21.73 per share. | 26 Jan 2022 | 479 | 479 (0%) | 0% | 21.7 | 10,409 | Shares of Beneficial Interest |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 1,219 | 1,219 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 1,219 | 2,440 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Kathleen McGroddy-Goetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,021 | 2,021 | - | - | Restricted Stock Unit |